CYTOGEN CORPORATION Trademark Portfolio
CYTOGEN CORPORATION owns 0 live USPTO trademarks across 3 Nice classes. Earliest filing: 1985-12-23; most recent: 2005-10-27.
Portfolio Overview
| Total Marks | 24 |
|---|---|
| Live Marks | 0 |
| Registered | 0 |
| Pending | 0 |
| Earliest Filing | 1985-12-23 |
| Latest Filing | 2005-10-27 |
Top Classes
Class 005 (Pharmaceuticals), Class 042 (Software & IT), Class 001 (Chemicals)
Recently Filed Applications
- TARGETING THE SITES AND STAGES OF CANCER PROGRESSION — filed 2005-10-27 (Abandoned)
- CORE — filed 2005-10-27 (Abandoned)
- CENTER OF READING EXCELLENCE — filed 2005-10-27 (Abandoned)
- STAMP — filed 2005-10-27 (Abandoned)
- STROMAL TARGETED ABLATION OF MULTIPLE PATHWAYS — filed 2005-10-27 (Abandoned)
Top Marks
- QUADRAMET — Cancelled
- CYTOGEN — Cancelled
- CYTOGEN — Cancelled
- ONCO-RAD — Cancelled
- THROMBO-SCINT — Cancelled
- ONCO-THER — Cancelled
- THROMBO-SCAN — Cancelled
- ONCO-SCINT — Cancelled
- CYTOGEN — Cancelled
- CYTOGEN — Cancelled
- STROMAL TARGETED ABLATION OF MULTIPLE PATHWAYS — Abandoned
- CENTER OF READING EXCELLENCE — Abandoned
- CORE — Abandoned
- STAMP — Abandoned
- TARGETING THE SITES AND STAGES OF CANCER PROGRESSION — Abandoned
- CYTOGEN INNOVATION IS OUR BUSINESS — Abandoned
- PROSTATHER — Abandoned
- 7E11 — Abandoned
- AMERICAN BIOIMAGING — Abandoned
- ABTIDE — Abandoned
- PIE — Abandoned
- SER — Abandoned
- SYNGENE — Abandoned
- ONCOTC — Abandoned